Circulating biomarkers determining inflammation in atherosclerosis progression
G Siasos, V Tsigkou, E Oikonomou… - Current Medicinal …, 2015 - ingentaconnect.com
Atherosclerosis is the main underlying pathology of cardiovascular disease and is
precipitated by various hereditary and non-hereditary risk factors. Inflammation is …
precipitated by various hereditary and non-hereditary risk factors. Inflammation is …
Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective
V Mallika, B Goswami, M Rajappa - Angiology, 2007 - journals.sagepub.com
Atherosclerosis is the root cause of the biggest killer of the 21st century. Mechanisms
contributing to atherogenesis are multiple and complex. A number of theories—including the …
contributing to atherogenesis are multiple and complex. A number of theories—including the …
Natural products in regression and slowing of progression of atherosclerosis
K Prasad - Current Pharmaceutical Biotechnology, 2010 - ingentaconnect.com
Many natural products, including vitamin E, garlic, purpurogallin, flaxseed and its
components [secoisolariciresinol diglucoside (SDG) and flax lignan complex (FLC)] and …
components [secoisolariciresinol diglucoside (SDG) and flax lignan complex (FLC)] and …
Nutraceutical therapies for atherosclerosis
Atherosclerosis is a chronic inflammatory disease affecting large and medium arteries and is
considered to be a major underlying cause of cardiovascular disease (CVD). Although the …
considered to be a major underlying cause of cardiovascular disease (CVD). Although the …
Inflammation in the molecular pathogenesis of cancer and atherosclerosis
F Vidal-Vanaclocha - Reumatología clinica, 2009 - Elsevier
Chronic inflammation, atherosclerosis and cancer are leading causes of death in
industrialized society. Epidemiological studies have shown that chronic inflammation …
industrialized society. Epidemiological studies have shown that chronic inflammation …
The effects of pro-inflammatory and anti-inflammatory agents for the suppression of intimal hyperplasia: an evidence-based review
Anti-atherogenic therapy is crucial in halting the progression of inflammation-induced intimal
hyperplasia. The aim of this concise review was to methodically assess the recent findings of …
hyperplasia. The aim of this concise review was to methodically assess the recent findings of …
The role and predictive value of cytokines in atherosclerosis and coronary artery disease
D Tousoulis, EK Economou… - Current medicinal …, 2015 - ingentaconnect.com
Atherosclerosis is currently regarded as a chronic inflammatory disease that is mediated by
several types of cells and molecules. Emphasis has been placed on the role of cytokines …
several types of cells and molecules. Emphasis has been placed on the role of cytokines …
[HTML][HTML] Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life
R Kelishadi - The open cardiovascular medicine journal, 2010 - ncbi.nlm.nih.gov
Atherogenesis starts from the fetal life, and its natural course consists of interrelations
between traditional risk factors and inflammatory, immune, and endothelial biomarkers …
between traditional risk factors and inflammatory, immune, and endothelial biomarkers …
Inflammatory markers in hyperlipidemia: from experimental models to clinical practice
The role of inflammation in the development and progression of cardiovascular diseases is
well established. Systemic inflammation and immune system play a central role in …
well established. Systemic inflammation and immune system play a central role in …
Anti-atherosclerotic molecules targeting oxidative stress and inflammation
A Adameova, YJ Xu, TA Duhamel… - Current …, 2009 - ingentaconnect.com
The accumulation of lipids within arteries remains to be the initial impulse for the
pathogenesis of atherosclerosis; however, both inflammation and oxidative stress are …
pathogenesis of atherosclerosis; however, both inflammation and oxidative stress are …